This substance misuse and sexual health blood borne virus strategy has been produced jointly by the tri-borough of Hammersmith and Fulham, the Royal Borough of Kensington and Chelsea and Westminster City Council to ensure that prevention, diagnosis and treatment of hepatitis C has an increased focus.
Resources
Medical professional
Around 216,000 people in the UK are living with hepatitis C so it is important that all medical professionals have access to the latest training, information and advice on hepatitis C management. Find here links to relevant materials for clinicians, nurses, GPs, prison healthcare staff and other medical professionals.
Showing 331 to 340 of 349 resources
-
Tri-borough Substance Misuse and Sexual Health Blood Borne Virus Strategy 2014-2016: Hammersmith & Fulham, Royal Borough of Kensington & Chelsea, and Westminster City Council
Greater London Jul 2014 Strategy & Planning PDF -
Understanding the pathway: barriers to data collection and onward referral to specialist hepatitis C services for PWID in London
This report, from the London Joint Working Group on Substance Use and Hepatitis C, examines barriers to data collection and onward referral to specialist hepatitis C services for people who inject drugs in London.England, Greater London Reports & Research PDF -
Understanding the Sexual Health and Blood Borne Virus Risk Behaviours of Defined 'at risk' Groups
This report outlines the findings of research with drug users and the staff that support them related to harms associated with chemsex, transactional sex; and the use of image and performance enhancing drugs (IPEDs). Twos aims of the report were to describe the risk-taking behaviours in relation to drug taking, sexual health and transmission of BBV (blood borne virus) of the three target groups and inform the development of a training programme for services providers on sexual health and blood borne viruses for the three defined groups.Scotland 07 Sep 2020 Reports & Research PDF -
United Nations Common Position on Ending HIV, TB and Viral Hepatitis through Intersectoral Collaboration
This common position paper outlines shared principles and key actionable areas within and beyond the health sector to address HIV, tuberculosis and viral hepatitis in Europe and central Asia, and is signed by 14 UN organisations.Rest of World Reports & Research PDF -
Unlinked anonymous HIV and viral hepatitis monitoring among PWID: 2017 report
This report presents an overview of the trends between 2006 and 2016 for HIV, hepatitis B, hepatitis C and risk behaviours from the ongoing Unlinked Anonymous Monitoring Survey, which is targeted at people who inject psychoactive drugs, such as heroin, crack cocaine and amphetamines.UK Reports & Research PDF -
Unlinked Anonymous Monitoring (UAM) Survey of HIV and viral hepatitis among PWID: 2020 report
The 2020 edition of the Unlinked Anonymous Monitoring (UAM) Survey of HIV and viral hepatitis among PWID contains a number of relevant updates on hepatitis C among injecting drug users, including: • The proportion of UAM participants with antibodies to hepatitis C (HCV) (i.e. ever infected) who have markers of chronic infection (RNA) has decreased from 58% in 2011 when it was first measured to 42% in 2019; this corresponds with the timing of the scale-up of direct acting antiviral treatment against HCV among PWIDUK 06 Oct 2020 Reports & Research PDF -
Vertical transmission of hepatitis C: towards universal antenatal screening in the era of new direct acting antivirals (DAAs)? Short review and analysis of the situation in Switzerland
This article uses the example of Switzerland to look at how recent developments in hepatitis C therapy might impact upon the prevention of hepatitis C vertical (i.e. mother to baby) transmission. It finds that universal screening for hepatitis C among pregnant women should be urgently re-evaluated in the light of the new treatments which are now available.Rest of World Feb 2016 Reports & Research PDF -
Webinar: Mitigating the impact of COVID-19 on hepatitis C testing
This is a recording of a webinar focusing on how services can mitigate the impact of COVID-19 on hepatitis C testing and find alternative ways to test people. The first part of the webinar consisted of three presentations: 1/ Overview of testing, before and after COVID-19 - Helen Hampton, Lead Clinical Nurse for Blood Borne Virus, We Are With You 2/ Outreach testing during the COVID-19 lockdown - Julian Surey, Find and Treat Team 3/ Postal testing or self-testing - Tracey Kemp, National Hepatitis C Strategy Lead, Change Grow LiveUK 22 Oct 2020 Case study, Tools & Templates, Strategy & Planning Video -
Webinar: Under-served groups for hepatitis C testing and treatment
This webinar sought to look at how services can provide hepatitis C testing and treatment to people who have been traditionally under-served by health services. This workshop sought to discuss: - Sex workers - Gypsy, Roma and Traveller people - South Asian communities - Migrants For each of these groups, this video features a presentation exploring the general barriers to healthcare that they face and examples of projects which have improved access to healthcare for them along with a Q&A session at the end.UK 22 Oct 2020 Case study, Training, Strategy & Planning Video -
WHO Guidelines for the screening, care and treatment of persons with chronic hepatitis C infection
These guidelines, developed by the World Health Organisation, promote the transition to newer, more effective medicines that have the potential to cure most persons living with hepatitis C infection. They also provide guidance on which specific regimens should be used based on a patient’s clinical history as well as genotype, and are intended to promote the scale-up of hepatitis C treatment.UK, Rest of World Apr 2016 Other, Strategy & Planning PDF